Health
China’s daily ibuprofen, paracetamol production tops 200m tablets
China’s daily production capacity of fever and pain relievers ibuprofen and paracetamol has exceeded 200 million tablets, while the daily output reached 190 million.
The maximum daily output of children’s antipyretic medicine reached 1.12 million bottles as the country strives to expand its anti-COVID-19 medical supply.
Wang Jiangping, vice minister of industry and information technology shared the figures at a press briefing Thursday.
The daily output of ibuprofen and paracetamol had increased by more than four times compared with early December as producers across the country have stepped up the output of medicine, masks, vaccines, and other anti-COVID-19 medical supplies.
However, daily production capacity of COVID-19 antigen test kits had expanded from about 60 million in early December to some 110 million.
The country had also strengthened cross-region transfers of medical supplies.
According to Wang, by Wednesday, a total of 174 million ibuprofen tablets and 60 million paracetamol tablets had been allocated to key areas across the country.
-
Features1 week agoHow ADC leadership crisis put Atiku’s 2027 ambition at risk
-
Energy7 days agoNNPC plans 5–10% stock market listing, targets 2027 for IPO preparations
-
Business1 week agoLoveWorld Expo 2026 to showcase global innovations, emerging technologies in Lagos
-
Business4 days agoDisCos urge Minister to end blame game, apologise to Nigerians over blackouts
-
Latest1 week ago2027: No Court rulings can keep me off the ballot, Atiku insists
-
Latest1 week ago2027: Wike declares Obi’s political wave dead, dismisses chances of presidential victory
-
Health5 days agoStudy links Pfizer COVID-19 vaccine to higher death rates than Moderna shot
-
Latest1 week agoHow internal party disputes could shape the 2027 elections


